- Drugs
- Tuesday, 07 Jan 2020
Harvest Files Suit Against Falcon International, Inc.
Harvest Health & Recreation Inc. (CSE: HARV, OTCQX: HRVSF) ("Harvest"), a vertically integrated cannabis company with one of the largest and deepest footprints in the U.S., announced that yesterday Harvest filed suit against Falcon International, Inc. ("Falcon") requesting termination and rescission of the Merger Agreement ("Transaction") and return of money Harvest paid to Falcon under the Merger Agreement. As detailed in the Complaint, filed in U.S. Federal Court, District of Arizona, Harvest alleges that Falcon has failed to meet its legal obligations in multiple ways, including the failure to provide auditable financial records, which precludes Harvest from moving forward with the Transaction.
While Harvest remains committed to the long-term potential of legal cannabis sales in California, current market conditions make it difficult to operate profitably there today. If the Transaction does not close for any reason, including those enumerated in the Complaint, the company plans to remove the contribution attributable to Falcon from its 2020 pro forma guidance. Harvest expects overall 2020 pro forma profitability would improve without the revenue contribution from Falcon.
Related Industry Updates
China Transmucosal Drug Delivery Systems Market Research With Size, Growth, Manufacturers, Segments And 2027 | 3M, Acrux, GW Pharmaceuticals
Feb 05, 2021
Novartis scraps sale of assets including COVID-19 hopeful to Indis's Aurobindo Pharma
Apr 02, 2020
Emerging nations represent an excellent opportunity for the pharmaceutical industry to develop anti-fungal drugs
Sep 24, 2019
Malaria Diagnostics Market is expected to reach US$ 1,200.24 million by 2030
Jan 09, 2024
Vaccines: A Powerful Panacea to Impound Epidemic
Aug 19, 2019
Paracetamol Market is expected to reach US$ 14,254.44 million by 2030
Feb 02, 2024
Pfizer to Acquire Metsera with Next-Generation Obesity Portfolio
Feb 24, 2026